Dozens of patients sue GLP-1 drugmakers over vision-loss claims as of September 22, the same month employers begin rethinking weight-bias policy as the drugs normalize in team meals and office culture.
Dozens of patients sue GLP-1 drugmakers over vision-loss claims as of September 22, the same month employers begin rethinking weight-bias policy as the drugs normalize in team meals and office culture.